About Careers Internship MedBlog Contact us

Low Adenosine Kinase in Liver may be a Risk Factor for Cancer Development

by Iswarya on April 11, 2019 at 3:53 PM
Font : A-A+

Low Adenosine Kinase in Liver may be a Risk Factor for Cancer Development

New study finds that reduced hepatic adenosine kinase expression (ADK) raises the susceptibility to the acute toxic effects of a carcinogen. Low ADK in the liver might be a risk factor and biomarker for the development of cancer. The findings of the study are published in the Journal of Caffeine and Adenosine Research.

Combined results from the study of human liver cancer samples and mice with reduced levels of ADK expression support these findings.


In the article entitled "Adenosine Kinase Deficiency Increases Susceptibility to a Carcinogen," Rkia El-Kharrag, Ph.D., Randy Owen, BSc, and Detlev Boison, Ph.D., Legacy Research Institute, Portland, OR, showed that 64% of patients with liver cancer had lower ADK expression.

ADK is highly expressed in the liver, where it regulates adenosine levels and is important in controlling hepatic metabolism. The researchers used transgenic technology to generate mice with reduced ADK expression and then exposed them to a carcinogen to study the effects on the animals' body weight and survival.

"These results might represent a very significant advance in the field. Further studies should confirm if adenosine kinase represents a new biomarker or a pharmacological target in liver cancer," says Editor-in-Chief of Journal of Caffeine and Adenosine Research Sergi Ferré, MD, PhD, and his research colleagues in the Integrative Neurobiology Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD.

Source: Eurekalert


Recommended Readings

Latest Research News

Softening Stem Cells Enhances Hair Growth Potential
The scientists discovered that when the stem cells in the hair follicle are made softer, they have a higher chance of growing hair.
Potential New Strategy for Ischemic Stroke Discovered
A combinatorial therapy provided promising beneficial results among people with ischemic stroke.
Is Speech Therapy the Answer to Voice Problems in Parkinson's Disease Patients
In Parkinson's disease patients voice disorders are quite common. A new combination therapy had greater effects on the voice.
 New Insights into How the Immune System Responds to Spinal-Cord Injuries
New study findings delineate how aging affects the immune response following Spinal cord injury (SCI) and highlight the participation of the spinal cord meninges in repair.
Nearsightedness: Atropine Eye Drops may Slow Progression in Kids
A recent clinical trial suggests that the first medication therapy to reduce the progression of nearsightedness in children could be on the way.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Low Adenosine Kinase in Liver may be a Risk Factor for Cancer Development Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests